Comprehensive analysis of the intrathecal B-cell response in patients with multiple sclerosis [MS]

被引：0
|
作者：
Finney-Stable, Antara [1 ]
Liang, Allison [1 ]
Lin, Jerry [1 ]
Sadiq, Saud [1 ]
机构：
[1] Tisch Multiple Sclerosis Res Ctr, New York, NY USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.392
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis
    Kulakowska, Alina
    Mroczko, Barbara
    Mantur, Maria
    Lelental, Natalia
    Tarasiuk, Joanna
    Kapica-Topczewska, Katarzyna
    Schulz, Ute
    Lange, Peter
    Zimmermann, Ruediger
    Kornhuber, Johannes
    Lewczuk, Piotr
    METHODS, 2012, 56 (04) : 528 - 531
  • [22] Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response
    Derfuss, T
    Hohlfeld, R
    Meinl, E
    JOURNAL OF NEUROLOGY, 2005, 252 (08) : 968 - 971
  • [23] Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients
    Feki, Sawsan
    Damak, Mariem
    Sakka, Salma
    Ben Ali, Yesmine
    Mejdoub, Sabrina
    Bouattour, Nadia
    Hachicha, Hend
    Mhiri, Chokri
    Masmoudi, Hatem
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients
    Sawsan Feki
    Mariem Damak
    Salma Sakka
    Yesmine Ben Ali
    Sabrina Mejdoub
    Nadia Bouattour
    Hend Hachicha
    Chokri Mhiri
    Hatem Masmoudi
    Scientific Reports, 12
  • [25] Is an intrathecal kappa-chain oriented immune response typical of Multiple Sclerosis (MS)?
    Crespi, I.
    Serino, R.
    Saliva, E.
    Marchiando, M.
    Campisi, M. P.
    Sulas, M. G.
    Vecchio, D.
    Comi, C.
    Cantello, R.
    Bellomo, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 326 - 326
  • [26] Genetic analysis of B-cell translocation gene 1 polymorphisms in multiple sclerosis
    Camina-Tato, M.
    Tur, C.
    Tellez, N.
    Rio, J.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S195 - S195
  • [27] Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using biomarkers
    Alvarez, E.
    Piccio, L.
    Mikesell, R. J.
    Trinkaus, K.
    Lancia, S.
    Parks, B. J.
    Naismith, R. T.
    Cross, A. H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 358 - 358
  • [28] B-cell activation and treatment effects in multiple sclerosis
    Bornsen, Lars
    Christensen, Jeppe Romme
    Ratzer, Rikke
    Sondergaard, Helle Bach
    Sorensen, Per Soelberg
    Selleberg, Finn
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 9 - 9
  • [29] B-Cell Targeting Agents in the Treatment of Multiple Sclerosis
    Tiffany J. Braley
    Benjamin M. Segal
    Current Treatment Options in Neurology, 2013, 15 : 259 - 269
  • [30] Ocrelizumab: a B-cell depleting therapy for multiple sclerosis
    Jakimovski, Dejan
    Weinstock-Guttman, Bianca
    Ramanathan, Murali
    Kolb, Channa
    Hojnacki, David
    Minagar, Alireza
    Zivadinov, Robert
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (09) : 1163 - 1172
12345